How Much Did ProtTech Raise?
Funding & Key Investors

ProtTech has secured $43K in recent financing, contributing to a total funding amount of $43K. This substantial expansion capital injection signifies a significant growth phase for the company, likely aligning with a Series B/C stage of development as it scales its operations and market reach.

What is ProtTech?

ProtTech
Business ServicesResearch & Development

ProtTech Analytical LLC. operates as a dedicated contract bioanalytical laboratory, focused on addressing complex bioanalytical challenges within the pharmaceutical and biotechnology sectors, as well as academia. The company leverages its expertise in analytical chemistry, Drug Metabolism and Pharmacokinetics (DMPK), protein characterization, and biochemistry, drawing on over a decade of experience from leading industry players. ProtTech's core competency lies in developing and validating sensitive, robust analytical methods, primarily utilizing Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) for the quantitative measurement of drugs and their metabolites in biological matrices across all stages of drug discovery and development. They also specialize in high-throughput assays for endogenous biomarkers and their metabolites, offering flexible business operations to meet diverse client needs with a commitment to quality data at competitive costs.

How much funding has ProtTech raised?

ProtTech has raised a total of $43K across 1 funding round:

2021

Debt

$43K

Debt (2021): $43K with participation from PPP

Key Investors in ProtTech

PPP

Public-Private Partnership

What's next for ProtTech?

With the recent influx of substantial expansion capital, ProtTech is strategically positioned for accelerated growth. This funding is expected to fuel advancements in their bioanalytical service offerings, potentially expanding their laboratory infrastructure, enhancing their technological capabilities in LC-MS/MS and other analytical techniques, and broadening their client base within the pharmaceutical and biotechnology industries. The company's focus on solving challenging bioanalytical problems and providing quality data suggests future investments may target research and development for novel assay development, expansion into new therapeutic areas, or strategic partnerships to enhance their market penetration and solidify their position as a leading contract bioanalytical service provider.

See full ProtTech company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesField Service Management
Advertising NetworksBusiness Services
Business ServicesProject ManagementEducationTraining
Business ServicesSoftware Testing

Frequently Asked Questions Regarding ProtTech Financial Insights

What are the most recent funding rounds that ProtTech has completed, and what were the funding rounds?
ProtTech has recently completed 1 funding rounds: Debt on Jan 29, 2021.
What is the total amount of funding ProtTech has raised to date?
ProtTech has raised a total of $43K in funding to date.
How many funding rounds has ProtTech completed?
ProtTech has completed 1 funding rounds.
How much funding did ProtTech raise in its most recent funding round?
ProtTech raised $43K in its most recent funding round.
Who are the lead investors in ProtTech's latest funding round?
The lead investor in ProtTech's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in ProtTech's history?
The largest funding round in ProtTech's history was $43K.
See more information about ProtTech